Clinical trial
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial…
NCT00002976 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00002976 |
|---|---|
| Title | Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer |
| Official title | A Randomized Double-Blinded Trial of Estrogen Replacement Therapy Versus Placebo in Women With Stage I or II Endometrial Adenocarcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group SWOG Cancer Research Network |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | conjugated estrogens |
| Enrollment | 2,108 |
| Start date | Jun 1, 1997 |
| Primary completion | Jul 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 11, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: